BRAINTREE, Mass., Dec. 20, 2018 /PRNewswire/ -- Haemonetics
Corporation (NYSE:HAE) announced that the Company intends to
publish third quarter fiscal 2019 financial results at 6:00 am EST
on Tuesday, February 5, 2019. The
Company will hold a conference call with investors and analysts to
discuss results and answer questions at 8:00
am EST on February 5,
2019.
The call can be accessed with the following information:
U.S. / Canada toll free (877)
848-8880; International (716) 335-9512
Conference ID required for access: 4381128
A live webcast of the call can be accessed on Haemonetics'
investor relations website. Webcast Link:
https://edge.media-server.com/m6/p/wcre57f8
Webcast replay will be available from February 5, 2019 after 10:00 am EST.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated
to providing a suite of innovative hematology products and
solutions for customers to help them improve patient care and
reduce the cost of healthcare. Our technologies address important
medical markets: blood and plasma component collection, the
surgical suite, and hospital transfusion services. To learn more
about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Gerry Gould, VP-Investor
Relations
(781) 356-9402
gerry.gould@haemonetics.com
Olga Vlasova, Sr. Mgr.-Investor
Relations
(781) 356-9763
olga.vlasova@haemonetics.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-2019-results-february-5-2019-300769528.html
SOURCE Haemonetics Corporation